NCT02491723View on ClinicalTrials.gov

Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Bronchiectasis
Interventions
DRUG

Azithromycin

Patients with bronchiectasis treated with Azithromycin for three to five days.

Trial Locations (1)

200433

Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors
lead

Jin-Fu Xu

OTHER

NCT02491723 - Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa | Biotech Hunter | Biotech Hunter